Azulfidine EN-tabs has been approved to treat ulcerative colitis, rheumatoid arthritis, and juvenile rheumatoid arthritis. The prescription medication comes in tablet form, and is usually taken two to six times per day. The dosage that your healthcare provider prescribes will depend on factors such as your age, weight, and other medications you are taking. Possible side effects of Azulfidine EN-tabs include loss of appetite, headaches, and vomiting.
What Is Azulfidine EN-Tabs?
Who Makes Azulfidine EN-Tabs?
Azulfidine EN-tabs is manufactured by Pfizer, Inc.
How Does Azulfidine EN-Tabs Work?
Azulfidine EN-tabs belongs to a group of medications called aminosalicylates. It is thought that the medication works by inhibiting the production of inflammatory chemicals in the lining of the
colon. It decreases the production of prostaglandins and leukotrienes, chemicals that lead to the inflammation caused by ulcerative colitis.
It is not fully understood exactly how Azulfidine EN-tabs works for rheumatoid
arthritis and juvenile rheumatoid arthritis. However, it is thought to likely work by decreasing inflammation and also by affecting the immune system.
Azulfidine EN-tabs has a special "enteric coating," which prevents the tablets from dissolving until they reach the stomach. This helps prevent stomach irritation.
Add this article to your Favorites
Email this article
Print